COGNITION THERAPEUTICS INC

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Results of Operations and Financial Condition

Other Events

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Other Events

Other Events

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Other Events

Entry into a Material Definitive Agreement

Other Events

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Other Events

Other Events

Other Events

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Khattar Jack A.

Monia Brett P

RICHSTONE ELLEN B

Wallace Peggy

BIOS Fund II QP, LP; BIOS Memory SPV I, LP; BIOS Fund I, LP; BIOS Fund I QP, LP; BIOS Fund II, LP; BIOS Capital Management, LP; Fletcher Aaron G.L.; Bios Equity Partners II, LP; Bios Equity Partners, LP; BIOS Advisors GP, LLC

Doyle John Brendan

Doyle John Brendan

Caggiano Anthony

Ricciardi Lisa

Ricciardi Lisa

Doyle John Brendan

Caggiano Anthony

Ricciardi Lisa

Doyle John Brendan

Caggiano Anthony

Ricciardi Lisa

Doyle John Brendan

Caggiano Anthony

Fletcher Aaron G.L.

BIOS Memory SPV I, LP

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC